ORCHID PHARMA
|
The Current P/E Ratio of ORCHID PHARMA is 67.11.
| Share Price | ₹687.8 | Feb 10,2026 |
| Market Cap | ₹3,487.1 Cr | |
| Earnings-TTM | ₹52.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 67.11x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ORCHID PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹3,487.1 Cr] as on Feb 10,2026
(/) Earnings [ ₹52.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 67.11x ]
Thus, for ORCHID PHARMA , the investors are currently willing to pay 67.11 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ORCHID PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ORCHID PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of ORCHID PHARMA
PE Ratio Performance Analysis for ORCHID PHARMA
- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.19x.
- ORCHID PHARMA 's operated at median p/e ratio of 33.87x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2024 at 57.52x.
- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does ORCHID PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ORCHID PHARMA | 51.96 | 67.11 | 3,487.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.24 | 409,698.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 69.17 | 171,878.0 |
| CIPLA LTD | 4,544.70 | 23.99 | 109,030.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 64.51 | 138,062.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.25 | 106,023.0 |
| MANKIND PHARMA LTD | 1,796.65 | 47.61 | 85,533.2 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.09 | 89,273.1 |
| LUPIN LTD | 4,347.53 | 23.17 | 100,736.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 18.95 | 66,559.9 |
| ABBOTT INDIA LTD | 1,508.95 | 37.87 | 57,148.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ORCHID PHARMA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.09x |
| Max industry PE | 69.17x |
| Median industry PE | 37.24x |
| Average industry PE | 38.81x |
You may also like the below Video Courses